Preview: Myriad Genetics's Earnings
Portfolio Pulse from Benzinga Insights
Myriad Genetics (NASDAQ:MYGN) is set to release its quarterly earnings report on August 3, 2023. Analysts estimate an earnings per share (EPS) of $-0.08. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $21.77 as of August 1, with a 52-week decrease of 22.23%.
August 04, 2023 | 11:59 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Myriad Genetics is expected to report an EPS of $-0.08. The company's share price has historically been affected by earnings reports. The stock is currently down 22.23% over the last 52 weeks.
The company's earnings report is a significant event that can impact its stock price. Given the negative EPS estimate and the historical pattern of share price changes following earnings reports, it is likely that the stock price may decrease in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100